These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17960386)

  • 61. Pemetrexed (Alimta): a novel multitargeted antifolate agent.
    Adjei AA
    Expert Rev Anticancer Ther; 2003 Apr; 3(2):145-56. PubMed ID: 12722874
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pemetrexed in the treatment of relapsed/refractory primary central nervous system lymphoma.
    Raizer JJ; Rademaker A; Evens AM; Rice L; Schwartz M; Chandler JP; Getch CC; Tellez C; Grimm SA
    Cancer; 2012 Aug; 118(15):3743-8. PubMed ID: 22179954
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pemetrexed and oxaliplatin for metastatic colorectal cancer: results of a phase I Mayo Cancer Center Research Consortium trial, MC0248.
    Alberts SR; Kim GP; Mahoney MR; Gornet MK; Rubin J; Ames M; Goetz MP; Weinshilboum RM; Nicol SJ; Goldberg RM
    Clin Colorectal Cancer; 2007 Jul; 6(8):572-7. PubMed ID: 17681103
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pemetrexed in gastric cancer: clinical experience and future perspectives.
    Celio L; Buzzoni R; Longarini R; Marchianò A; Bajetta E
    Semin Oncol; 2002 Dec; 29(6 Suppl 18):63-8. PubMed ID: 12571814
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Irofulven as first line therapy in recurrent or metastatic gastric cancer: a phase II multicenter study by the Cancer Therapeutics Research Group (CTRG).
    Yeo W; Boyer M; Chung HC; Ong SY; Lim R; Zee B; Ma B; Lam KC; Mo FK; Ng EK; Ho R; Clarke S; Roh JK; Beale P; Rha SY; Jeung HC; Soo R; Goh BC; Chan AT;
    Cancer Chemother Pharmacol; 2007 Feb; 59(3):295-300. PubMed ID: 16783579
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Phase I dose-escalating study of biweekly fixed-dose rate gemcitabine plus pemetrexed in patients with advanced solid tumors.
    Yuan Y; Cohen DJ; Love E; Yaw M; Levinson B; Nicol SJ; Hochster HS
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):371-8. PubMed ID: 20978761
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Use of pemetrexed in breast cancer.
    Dittrich C
    Semin Oncol; 2006 Jun; 33(3 Suppl 9):S24-8. PubMed ID: 16797379
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A phase II multicenter study of two different dosages of pemetrexed given in combination with cyclophosphamide as first-line treatment in patients with locally advanced or metastatic breast cancer.
    Dittrich C; Solska E; Manikhas A; Eniu A; Tjulandin S; Anghel R; Musib L; Frimodt-Moller B; Liu Y; Krejcy K; Láng I
    Cancer Invest; 2012 May; 30(4):309-16. PubMed ID: 22468806
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Phase I trial and pharmacokinetic study of pemetrexed in children with refractory solid tumors: the Children's Oncology Group.
    Malempati S; Nicholson HS; Reid JM; Blaney SM; Ingle AM; Krailo M; Stork LC; Melemed AS; McGovern R; Safgren S; Ames MM; Adamson PC;
    J Clin Oncol; 2007 Apr; 25(12):1505-11. PubMed ID: 17442992
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pemetrexed for previously treated patients with metastatic gastric cancer: a prospective phase II study.
    Zhang DS; Jin Y; Luo HY; Wang ZQ; Qiu MZ; Wang FH; Li YH; Xu RH
    Br J Cancer; 2015 Jan; 112(2):266-70. PubMed ID: 25474247
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Phase II study of the multitargeted antifolate LY231514 (ALIMTA, MTA, pemetrexed disodium) in patients with advanced pancreatic cancer.
    Miller KD; Picus J; Blanke C; John W; Clark J; Shulman LN; Thornton D; Rowinsky E; Loehrer PJ
    Ann Oncol; 2000 Jan; 11(1):101-3. PubMed ID: 10690396
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Phase II study of pemetrexed disodium (Alimta) administered with oral folic acid in patients with advanced gastric cancer.
    Bajetta E; Celio L; Buzzoni R; Ferrari L; Marchianò A; Martinetti A; Longarini R; Becerra C; Ilardi C; John W
    Ann Oncol; 2003 Oct; 14(10):1543-8. PubMed ID: 14504056
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical and pharmacokinetic phase I study of multitargeted antifolate (LY231514) in combination with cisplatin.
    Thödtmann R; Depenbrock H; Dumez H; Blatter J; Johnson RD; van Oosterom A; Hanauske AR
    J Clin Oncol; 1999 Oct; 17(10):3009-16. PubMed ID: 10506594
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: a multi-institutional phase II study.
    Celio L; Sternberg CN; Labianca R; La Torre I; Amoroso V; Barone C; Pinotti G; Cascinu S; Di Costanzo F; Cetto GL; Bajetta E
    Ann Oncol; 2009 Jun; 20(6):1062-7. PubMed ID: 19218305
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A phase II trial of pemetrexed in advanced breast cancer: clinical response and association with molecular target expression.
    Gomez HL; Santillana SL; Vallejos CS; Velarde R; Sanchez J; Wang X; Bauer NL; Hockett RD; Chen VJ; Niyikiza C; Hanauske AR
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):832-8. PubMed ID: 16467096
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficacy of oxaliplatin plus pemetrexed in chemotherapy pretreated metastatic castration-resistant prostate cancer.
    Dorff TB; Tsao-Wei DD; Groshen S; Boswell W; Goldkorn A; Xiong S; Quinn DI; Pinski JK
    Clin Genitourin Cancer; 2013 Dec; 11(4):416-22. PubMed ID: 24099865
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Further study on pemetrexed based chemotherapy in treating patients with advanced gastric cancer (AGC).
    Liu J; Huang XE; Feng JF
    Asian Pac J Cancer Prev; 2014; 15(16):6587-90. PubMed ID: 25169492
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pemetrexed in small-cell lung cancer: background and review of the ongoing GALES pivotal trial.
    Ferraldeschi R; Thatcher N; Lorigan P
    Expert Rev Anticancer Ther; 2007 May; 7(5):635-40. PubMed ID: 17492928
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Phase II study of cisplatin in advanced esophageal cancer and gastric cancer].
    Saitoh S; Sakata Y; Tamura Y; Itoh T; Tsushima K; Munakata A; Yoshida Y; Sasaki H; Matsukawa M; Tsuge M
    Gan To Kagaku Ryoho; 1989 Feb; 16(2):213-7. PubMed ID: 2645834
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Population pharmacokinetic analysis of ten phase II clinical trials of pemetrexed in cancer patients.
    Latz JE; Chaudhary A; Ghosh A; Johnson RD
    Cancer Chemother Pharmacol; 2006 Apr; 57(4):401-11. PubMed ID: 16322991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.